Literature DB >> 19589796

Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.

Christian Veltmann1, Christian Wolpert, Frederic Sacher, Philippe Mabo, Rainer Schimpf, Florian Streitner, Joachim Brade, Florence Kyndt, Juergen Kuschyk, Herve Le Marec, Martin Borggrefe, Vincent Probst.   

Abstract

AIMS: The diagnostic type I ECG in Brugada syndrome (BS) is often concealed and fluctuates between the diagnostic and non-diagnostic pattern. Challenge with intravenous ajmaline is used to unmask the diagnostic Brugada ECG. The aim of this study was to evaluate the safety of the test and to identify predictors for the response to an intravenous ajmaline challenge. METHODS AND
RESULTS: In four tertiary referral centres, 677 consecutive patients underwent an intravenous ajmaline challenge for diagnosis or exclusion of BS in accordance with the recommendations of the Brugada consensus conferences. Two hundred and sixty-two ajmaline challenges (39%) were positive. Male gender, familial BS, sudden cardiac arrest (SCA), first-degree AV-block, basal saddleback type ECG, and basal right bundle branch block were identified as predictors for a positive ajmaline challenge. A predictor for negative ajmaline test was the absence of ST-segment elevation at baseline. Six of 12 patients who had experienced SCA, and five of 25 patients with a familial sudden death exhibited a positive response to ajmaline. Only one patient (0.15%) developed sustained ventricular tachyarrhythmias (ventricular fibrillation) during ajmaline challenge, which was terminated by a single external defibrillator shock.
CONCLUSION: Ajmaline challenge is a safe procedure to unmask the electrocardiographic pattern of BS. Electrocardiographic and clinical parameters were identified to predict patients' response to ajmaline. The results of this study guide the clinician in which setting an ajmaline challenge is an appropriate diagnostic step.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589796     DOI: 10.1093/europace/eup189

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  17 in total

1.  Single oral flecainide dose to unmask type 1 Brugada syndrome electrocardiographic pattern.

Authors:  Sergio Dubner; Damián Azocar; Sebastián Gallino; Alfonso Rafael Cerantonio; Sergio Muryan; Juan Medrano; Carlos Bruno
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-05       Impact factor: 1.468

Review 2.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

Review 3.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-07-13       Impact factor: 6.343

Review 4.  [Brugada syndrome].

Authors:  Christian Veltmann; Hanno Oswald; Johann Bauersachs
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-09-20

5.  Risk stratification in young patients with channelopathies.

Authors:  N Sreeram; U Trieschmann; M Khalil; M Emmel
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

Review 6.  Risk stratification in electrical cardiomyopathies.

Authors:  Christian Veltmann; Rainer Schimpf; Martin Borggrefe; Christian Wolpert
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

7.  Clinical Profile and Long-Term Follow-Up of Children with Brugada Syndrome.

Authors:  Ibrahim El-Battrawy; Gretje Roterberg; Kim Schlentrich; Volker Liebe; Siegfried Lang; Boris Rudic; Erol Tülümen; Xiaobo Zhou; Martin Borggrefe; Ibrahim Akin
Journal:  Pediatr Cardiol       Date:  2019-11-20       Impact factor: 1.655

Review 8.  [Syncopes and channelopathies].

Authors:  Johanna Müller-Leisse; Christos Zormpas; Thorben König; David Duncker; Christian Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-15

Review 9.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

10.  Unmasked Brugada pattern by ajmaline challenge in patients with myotonic dystrophy type 1.

Authors:  Thomas Pambrun; Agustín Bortone; Patrick Bois; Bruno Degand; Sylvie Patri; Aurélie Mercier; Mohamed Chahine; Aurélien Chatelier; Damien Coisne; Alain Amiel
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-06-18       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.